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The mannose receptor (ManR, Mrc1) and asialoglycoprotein
receptor (ASGR, Asgr1 and Asgr2) are highly abundant endo-
cytic receptors expressed by sinusoidal endothelial cells and
parenchymal cells in the liver, respectively. We genetically
manipulated either receptor individually or in combination,
revealing phenotypic changes in female and male mice associ-
ated with changes in circulating levels of many glycoproteins.
Both receptors rise and fall in response to progesterone during
pregnancy. Thirty percent of Asgr2/ and 65% of Mrc1/
Asgr2/ mice are unable to initiate parturition at the end of
pregnancy, whereas Mrc1/ mice initiate normally. Twenty
five percent of Mrc1/Asgr2/ male mice develop priapism
when mating due to thrombosis of the penile vein, but neither
Mrc1/ nor Asgr2/ mice do so. The half-life for luteinizing
hormone (LH) clearance increases in Mrc1/ and Mrc1/
Asgr2/mice but not in Asgr2/mice; however, LH and tes-
tosterone are elevated in all three knockouts. The ManR clears
LH thus regulating testosterone production, whereas the ASGR
appears to mediate clearance of an unidentified glycopro-
tein that increases LH levels. More than 40 circulating glycopro-
teins are elevated >3.0-fold in pregnant Mrc1/Asgr2/
mice. Pregnancy-specific glycoprotein 23, undetectable in WT
mice (<50 ng/ml plasma), reaches levels of 1–10 mg/ml in the
plasma ofMrc1/Asgr2/ and Asgr2/mice, indicating it is
cleared by the ASGR. Elevation of multiple coagulation factors
in Mrc1/Asgr2/ mice may account for priapism seen in
males. These male and female phenotypic changes underscore
the key roles of the ManR and ASGR in controlling circulating
levels of numerous glycoproteins critical for regulating repro-
ductive hormones and blood coagulation.
The asialoglycoprotein receptor (ASGR),2 consisting of two
subunits designated Asgr1 and Asgr2, and the mannose recep-
tor (ManR), consisting of a single subunit designatedMrc1, are
highly abundant, glycan-specific, endocytic receptors that are
expressed by parenchymal cells (PC) and sinusoidal endothelial
cells (SEC) in the liver, respectively (1–6). The ASGR was first
identified by Ashwell and co-workers (7) on the basis of its
ability to rapidly remove glycoproteins bearing N-linked gly-
cans terminating with the structure Gal1,4GlcNAc (Fig. 1)
from the blood. Exogenous glycoproteins bearing glycans
terminating with the structure GalNAc1,4GlcNAc, Gal1,
4[Fuc1,3]GlcNAc (denoted LewisX), or in some species the
structure Sia2,6GalNAc1,4GlcNAc are also recognized by the
ASGR and rapidly cleared (9–11). PCs express 500,000 ASGR
sites at their plasmamembrane that are rapidly internalized and
replaced by recycling receptors (12). Mice that have had either
theAsgr1 orAsgr2 subunit ablated donot exhibit ASGRbinding
activity at the plasma membrane, yet apparently they do not
displaymajor increases in circulating glycoproteins bearing gly-
cans that should be recognized by the ASGR and do not exhibit
an evident phenotype (13–15). Physiological challenges have
been used to reveal functional deficiencies in Asgr1/ and
Asgr2/. For example,Marth and co-workers (16) have shown
that Asgr1/ and Asgr2/ mice exhibit increased resistance
to developing disseminated intravascular coagulation during
pneumococcal sepsis inducedwith increasing doses of bacteria.
Similarly, platelets subjected to cold storage, which exposes ter-
minal galactose at their surface, are cleared more slowly when
introduced into Asgr1/ and Asgr2/ mice than WT mice.
Thus, the ASGRmay also play a role in platelet clearance under
physiological circumstances (17).
The ManR was identified in macrophages and SECs in the
liver on the basis of its ability to clear glycoproteins bearing
oligomannose-type glycans (Fig. 1) from the blood (18). SECs
express 500,000ManR-binding sites at their plasmamembrane
that are rapidly internalized along with any bound ligand (2).
Important roles in innate immunity and clearance of glycopro-
teins from the blood have been attributed to theManRbased on
its ability to bind glycans on pathogens and glycoproteins such
as lysosomal enzymes (19, 20). Lee et al. (21) reported that
Mrc1/mice have elevated circulating levels of 52 unique pro-
teins, including lysosomal enzymes and procollagen fragments,
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clearly establishing a role for the ManR in clearance of glyco-
proteins bearing oligomannose-type glycans. Nonetheless,
Mrc1/mice did not manifest an obvious phenotype.
In earlier studies, we demonstrated that glycoproteins such
as luteinizing hormone (LH) bearing N-linked glycans termi-
nating with SO4-4-GalNAc1,4GlcNAc (Fig. 1) are cleared
from the blood by a dimeric form of the same ManR expressed
in SECs found in the liver (1, 22–24). Terminal GalNAc-4-SO4
is bound by a distinct region of the ManR (Mrc1), denoted as
the cysteine-rich or R-type lectin domain located at the N ter-
minus, whereas glycans containing terminal mannose are
bound by C-type lectin domains located near the transmem-
brane domain (25–28). The sulfotransferase GalNAc-4-sulfo-
transferase-1 (GalNAc-4-ST1, CHST8) mediates the addition
of SO4 to N-linked glycans terminating with GalNAc1,
4GlcNAc (Fig. 1) on LH (29–31), generating ligands that are
recognized by theManR.We determined thatN-linked glycans
on LH produced by GalNAc-4-ST1/ mice terminated with
Sia2,6GalNAc1,4GlcNAc instead of SO4-4-GalNAc1,
4GlcNAc (Fig. 1). As a consequence, LH levels were elevated
because LH was no longer cleared by the ManR, resulting in
higher levels of testosterone and estrogen inmales and females,
respectively (32). In these sulfotransferase knock-out mice,
males underwent precocious sexual development and had
enlarged seminal vesicles due to the elevated testosterone.
Female mice also underwent precocious sexual development,
had enlarged and highly vascularized uteri, andwere constantly
in estrus due to the elevated estrogen levels. The phenotype of
the GalNAc-4-ST1/mice supported our hypothesis that the
episodic rise and fall of LH levels critical for maximal stimula-
tion of the LH receptor in the testis and ovary depend not only
on regulated release of LH-containing granules by the pituitary
but also on rapid clearance of the released LH by the ManR
(Mrc1). Because the Kd value of the ManR for binding LH gly-
cans is well above the maximal levels of LH that are attained in
the blood, the half-life for clearance of LH by the ManR should
remain constant regardless of the concentration of LH in the
blood.However, the clearance rate should be determined by the
amount of ManR expressed.
We recently reported that expression of both the ASGR and
theManR increased in the liver of pregnantmice in response to
progesterone. We demonstrated that levels of receptor expres-
sion determined the rate of clearance from the blood of glyco-
proteins bearing glycans recognized by each receptor (9). As a
key exemplar ligand, we generated recombinant pregnancy-
specific glycoprotein 23 (PSG23), a member of the murine PSG
FIGURE1.SyntheticpathwaysproducingN-linkedglycans recognizedby themannoseandasialoglycoprotein receptors.Aglycan containing threeGlc,
nine Man, and two GlcNAc residues is transferred cotranslationally from dolichol-pyrophosphate to Asn-Xaa-(Ser/Thr) acceptor sequences on proteins in the
endoplasmic reticulum. Removal of outer Glc and Man residues and addition of GlcNAc residues produce a structure with two terminal GlcNAc residues.
Glycans on glycoproteins that contain a peptide recognition determinant that is recognized by either 1,4-GalNAcT3 or 1,4-GalNAcT4 and are expressed in
cells containing one or both transferases will bemodified with 1,4-GalNAc. The resulting structure can be further modified with SO4 linked to the 4-hydroxyl
of the GalNAc, Fuc linked to the 3-hydroxyl of the underlying GlcNAc, or Sia linked to the 6-hydroxyl of the GalNAc. In the absence of the recognition
determinant or either 1,4-GalNAcT3 or 1,4-GalNAcT4, theN-linked glycans with terminal GlcNAc aremodified with 1,4-linked Gal. The terminal Gal can be
modified with either 1,3- or 1,6-linked Sia or with underlying GlcNAc can be modified with 1,3-linked Fuc. Glycans containing Man or GlcNAc are
recognized by the ManR. Glycans containing terminal GalNAc-4-SO4 are recognized by a distinct region of the ManR, the Cys-rich or R-type lectin domain.
Glycans containing terminal1,4-linked Gal or GalNAc are recognized by the ASGR in the presence or absence of1,3-linked Fuc on the underlying GlcNAc. In
mice the presence of Sia or SO4 on the terminal GalNAc or Gal prevents recognition by the ASGR.
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sub-family within the greater carcinoembryonic antigen pro-
tein family (33, 34), bearing sevenN-linked glycans each termi-
nating with GalNAc-4-SO4. Clearance of this form of recombi-
nant PSG23 was abolished in Mrc1/ mice, consistent with
the proposed role of the ManR in LH clearance (9).
Whereas Mrc1/ and Asgr2/ mice were fertile, the pat-
tern of ASGR andManR expression suggested that one or both
receptors play a critical role in some aspect of pregnancy and/or
parturition. In addition, there were indications that hormonal
regulation was disrupted inMrc1/ and Asgr2/ mice even
though theywere fertile.We generatedMrc1/Asgr2/mice
and found that these double knock-out mice were not able to
initiate parturition at the proper time, suggesting that hormo-
nal regulation of this complex series of events was severely dis-
rupted in these double knock-out mice. We describe here the
characteristics of Mrc1/Asgr2/ mice as well as Mrc1/
andAsgr2/mice that provide new insights into the functions
of the ASGR and the ManR in reproduction as well as in other
processes such as blood coagulation. The large number of
plasma glycoproteins that are elevated in Mrc1/Asgr2/
mice indicates these receptors play important roles in many
different and diverse biological functions.
Results
Mrc1/Asgr2/ FemaleMice Fail to Initiate Parturition—
Mrc1/Asgr2/ mice were generated by breeding male
Mrc1/Asgr2/ mice with female Mrc1/Asgr2/ mice.
This was necessary because 61% of pregnantMrc1/Asgr2/
mice failed to initiate parturition the evening of 19.0 d.p.c. and
died when parturition was initiated at a later time. When
Asgr2/ female mice were carefully monitored, we found that
35% of pregnant Asgr2/ mice also failed to initiate parturi-
tion the evening of 19.0 d.p.c. and frequently died while
attempting to deliver post-mature pups (Fig. 2A). In contrast,
Mrc1/mice were not observed to have difficulty initiating or
completing parturition. The number and weight of pups pro-
duced by Asgr2/, Mrc1/, and Mrc1/Asgr2/ mice
were the same as WT mice following sacrifice on 18.0 and
19.0 d.p.c. Pups fromMrc1/Asgr2/mice that did not ini-
tiate parturition continued to gain weight indicating they were
viable and still growing.Death of the pups and themotherwhen
parturition was initiated between 21.0 and 23.0 d.p.c. likely
reflected an inability of the larger pups to transit the birth canal
(Fig. 2, panelA). TheAsgr2/Mrc1/mothers that delivered
viable pups rarely succeeded in getting pregnant a second time.
The initiation of parturition is a highly coordinated and com-
plex process that is not fully understood. Levels of the hormone
relaxin increase during the later stages of pregnancy and medi-
ate widening of the pubic symphysis to allow passage of pups
through the birth canal (35). The pubic symphysis was signifi-
cantly narrower in Mrc1/Asgr2/ than WT mice on 18.0
and 19.0 d.p.c. (Fig. 2, panel B). Furthermore, the symphysis of
overdue Mrc1/Asgr2/ and Asgr2/ mice was signifi-
cantly narrower than that of 19.0 d.p.c.WTmice. Progesterone,
produced by the ovary beginning on 4.0 d.p.c., is necessary for
the maintenance of pregnancy following implantation. Proges-
terone continues to rise until 15.0 d.p.c. of pregnancy, and we
have shown that this elevation drives increased expression of
the ASGR and the ManR (9). Progesterone, ASGR, and ManR
levels begin to decline late in pregnancy (9). A decrease in pro-
gesterone on 19.0 d.p.c. is essential for the initiation of parturi-
tion. RU486, an inactive analogue of progesterone, binds to the
progesterone receptor and blocks the action of progesterone
that is required to maintain pregnancy. RU486 induces prema-
ture parturition in WT mice when administered on 15.5 d.p.c.
of pregnancy (36). We used RU486 to initiate parturition in
WT,Mrc1/,Asgr2/, andMrc1/Asgr2/mice (10mice
per genotype). Pups were delivered within 24 h in 100% of the
WT and in 100% of theMrc1/mice. In contrast, parturition
was induced by RU486 within 24 h in only 50% of the Asgr2/
mice and within 48 h for the remaining 50% of the Asgr2/
mice. RU486 induced parturition within 24 h in only 10% of the
Mrc1/Asgr2/ mice. Of the remaining Mrc1/Asgr2/
mice, 40% eventually entered parturition after 48 h, whereas
50%never initiated parturition and diedwith postmature pups.
The inability to initiate parturition at the proper time appears
to be predominantly a consequence of loss of clearance by the
ASGR that is further amplified by loss of clearance by theManR
and cannot be overcome by administration of RU486.
MaleMrc1/Asgr2/mice also manifested abnormalities
thatwere not seen in eitherAsgr2/ orMrc1/mice. Twenty
five percent ofmaleMrc1/Asgr2/mice placedwith female
mice for the purpose of breeding developed priapism (Fig. 3,
panel A) and had to be sacrificed to prevent infection. Cross-
sections of the phallus revealed that the penile vein inmalemice
with priapismwas thrombosed (compareWT in Fig. 3, panel B,
FIGURE 2.Mrc1/Asgr2/ female mice were unable to initiate parturi-
tionandhadnarrowsymphysesonP18andP19comparedwithWTmice.
Panel A, femaleMrc1/Asgr2/micewerenot able to initiate parturitionon
19.0 d.p.c. and were unable to deliver large post-mature pups on later dates.
Anexampleof a femaleMrc1/Asgr2/mouseunable todeliver her pups is
shownwith a tail visible in the vaginal canal. Panel B, timed pregnantWT and
Mrc1/Asgr2/mice were sacrificed on P11, P15, P18, and P19 and when
2–3 days overdue (OD). The pubic symphysis was exposed and its widthmea-
sured. Thenumber ofmice in eachgroupequaled 10 except for overduemice
wheren6.p values for thedifference inwidthwerep0.02onP18 andp
0.002 on P19. The pubic symphyses of overdue (n 6) mice were also signif-
icantly narrower than P19 (n 10) mice with p 0.006.
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withMrc1/Asgr2/ in panels C–E). The thrombi varied in
age with some being acute (Fig. 3, panel C), and others demon-
strated a major influx of neutrophils (Fig. 3, panels D and E)
indicating the thrombus had developed 24–48 h before sacri-
fice. Priapism was never observed in either Asgr2/ or
Mrc1/ mice. Thus, lack of clearance by both the ASGR and
the ManR in male mice has an impact that is not seen in the
absence of clearance by only one of the two receptors.
Clearance of Endogenous LH in Asgr2/, Mrc1/, and
Mrc1/Asgr2/Mice—The glycoprotein hormone LH bears
N-linked glycans that terminate with 1,4-linked GalNAc-4-
SO4 (37–40), whereas FSH bears N-linked glycans that termi-
nate with Sia2,3/6Gal (see Fig. 1) (37–39). The ManR
expressed by SECmediates the clearance of glycoproteins bear-
ing two or more N-glycans with terminal GalNAc-4-SO4 (1, 9,
22, 23, 41). Following ablation of GalNAc-4-sulfotransferase-1
(CHST8, GalNAc-4-ST1),GalNAc-4-ST1/mice produce LH
that terminates with Sia2,6GalNAc instead of GalNAc-4-SO4,
resulting in a longer half-life in vivo and increased circulating
levels (32). We therefore expected that the half-life of endoge-
nous LH would also be prolonged in Mrc1/ mice as com-
pared with WT mice and that Mrc1/ mice would manifest
changes in their regulation of estrogen and testosterone
production.
We recently compared the clearance of an exogenous recom-
binant glycoprotein bearing multiple N-linked glycans in WT,
Asgr2/,Mrc1/, andMrc1/Asgr2/mice, and we dem-
onstrated that the ManR accounts for clearance of exogenous
glycoproteins bearing terminal GalNAc-4-SO4 on N-linked
glycans (1, 9, 23). Our present studies compared the clearance
rates for endogenous LH that bears glycans terminating with
GalNAc-4-SO4 in WT, Asgr2/, Mrc1/, and Mrc1/
Asgr2/mice by acutely blocking secretion of LH in castrated
malemicewith acyline and following the decrease in circulating
LHwith time as described previously (32). Endogenous LHwas
clearedwith a half-life of 8 and 7.5min, respectively, inWT and
Asgr2/mice (Fig. 4, panels A, B, and E). In contrast, LH was
cleared with a half-life of 15 and 12 min, respectively, in
Mrc1/ andMrc1/Asgr2/mice (Fig. 4, panels C–E). This
prolongation of half-life demonstrates that the ManR does
indeed account for the rapid clearance of endogenous LH in
vivo.
Measurement of circulating LH, FSH, and testosterone levels
in WT,Mrc1/, Asgr2/, andMrc1/Asgr2/male mice
revealed LH levels that were significantly elevated inMrc1/,
Asgr2/, and Mrc1/Asgr2/ mice compared with WT
mice (Fig. 5, panels A–C) and demonstrated greater variability
(Fig. 5, panel A). In contrast, circulating FSH levels did not
differ significantly in Mrc1/, Asgr2/, and Mrc1/
Asgr2/ mice compared with WT mice, although Asgr2/
mice did demonstrate greater variability compared with WT
mice (Fig. 5, panel B). In agreement with the elevated levels of
LH, testosterone levels were also elevated in Mrc1/,
Asgr2/, and Mrc1/Asgr2/ mice. Furthermore, the size
of seminal vesicles, which is sensitive to testosterone levels, was
significantly greater in Mrc1/, Asgr2/, and Mrc1/
Asgr2/ mice than in WT mice, consistent with the elevated
testosterone levels (Fig. 5, panels C and D).
Thus ablation of the ManR (Mrc1) resulted in increased lev-
els of circulating LH by prolonging the half-life for LH (Figs. 4,
panel C, and 5, panel A). Unexpectedly, loss of clearance by the
ASGR following ablation of Asgr2 also resulted in increased
levels of circulating LH and testosterone (Fig. 5, panels A and
B), even though the half-life for LH clearance was not altered
from that of WT (see Fig. 4, panels B and E). These phenotypic
changes seen in theAsgr2/ andMrc1/Asgr2/malemice
suggest that an unidentified glycoprotein that would normally
be cleared by the ASGR acts as a positive regulator of LH pro-
duction and release by the pituitary.
FIGURE 3.MaleMrc1/Asgr2/mice developedpriapismdue to thrombosis of the penile vein. Panel A, 25%ofMrc1/Asgr2/malemice developed
priapismwhen placed with female mice for breeding. An example of a maleMrc1/Asgr2/mouse with priapism is shown. Sections fromWT (panel B) and
Mrc1/Asgr2/ mice (panels C–E) revealed that the penile vein was thrombosed. Panels C–E, present progressively older thrombi as indicated by the
presence of increasing numbers of polymorphonuclear leukocytes. Increased numbers of red blood cells can be seen in the corpora cavernosa of Mrc1/
Asgr2/mice compared with WTmice (compare panels B and C).
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We examined the pituitaries of male Mrc1/, Asgr2/,
andMrc1/Asgr2/mice to determinewhether loss of clear-
ance by theManR and/or the ASGRhas an impact on glycopro-
tein hormone production and/or modification. The increase in
LHmRNA levels we observed inMrc1/mice (Fig. 6, panel
A) was unexpected because increased plasma testosterone lev-
els (Fig. 5, panel C) in response to lengthened LH half-life was
more likely to exert the known feedback effect of decreasing
LH production/release in the pituitary. LH mRNA levels
increased even more in Asgr2/ mice (Fig. 6, panel A) even
though their plasma testosterone was elevated (Fig. 5, panel C).
The LH mRNA elevation in Asgr2/ mice provides further
support for a positive regulator of LH production that is nor-
mally cleared by the ASGR. Plasma LH and testosterone levels
were elevated inMrc1/Asgr2/mice to a similar level as in
the single knock-out mice (Fig. 5, panels A and C), yet LH
mRNA levels were 3.0-fold lower in Mrc1/Asgr2/ mice
than Asgr2/mice (Fig. 6, panel A). Whereas for TSH, which
like LH, bears glycans terminating in GalNAc-4-SO4 (37, 38),
little change in TSH mRNA levels was observed in single
knock-out mice, whereas a 2–3-fold decrease was again seen in
Mrc1/Asgr2/mice comparedwith eitherWTorAsgr2/
mice (Fig. 6, panel B). FSH does not bear structures that are
recognized by either theManR or theASGR (see Fig. 1) (37, 38).
FSH mRNA levels did not change in either Mrc1/ or
Asgr2/ mice but did decrease nominally in Mrc1/
Asgr2/ mice (Fig. 6, panel C). The profile of decreases in
pituitary glycoprotein hormone mRNA synthesis in Mrc1/
Asgr2/ mice points to a broader impact of the concurrent
absence of both clearance receptors.
We also observed changes in pituitary transcript levels for
the glycosyltransferases that are responsible for the addition of
GalNAc in 1,4-linkage to N-linked glycans (B4galnt3 and
B4galnt4) and modification of the 1,4-linked GalNAc with
either SO4 (Galnac4st1) or sialic acid (St6gal1) (see Fig. 1). Loss
of clearance by either the ManR or the ASGR resulted in a
1.5–2.0-fold increase in Galnac4st1 and St6gal1 transcript lev-
els (Fig. 7, panels A and B). In contrast, loss of clearance by
both the ManR and the ASGR in double knock-out mice
reduced transcript levels not only for LH and TSH (Fig. 6,
FIGURE 4. Clearance of LH is prolonged inMrc1/ andMrc1/Asgr2/mice.WT (n 5),Mrc1/ (n 9), Asgr2/ (n 9), andMrc1/Asgr2/ (n
12) male mice were castrated. Five days later, mice were injected retro-orbitally with 10 g of acyline, and blood was collected at 0, 5,10, 20, and 30 min. The
amount of LH (ng/ml) in the plasma at each time point was determined by radioimmunoassay. Examples of clearance curves are shown for WT (panel A),
Mrc1/ (panel B), Asgr2/ (panel C), andMrc1/Asgr2/ (panel D). Half-lives were determined by non-linear regression using Prism 6.0. Themean and S.E.
for the half-lives determined for each group are shown in panel E. The half-life was significantly prolonged comparedwithWT in bothMrc1/ (8.4 min versus
15.6min, p 0.02) andMrc1/Asgr2/mice (8.4 versus 11.6min, p 0.04) butwas not significantly changed inAsgr2/mice. p valueswere determined by
unpaired t test.
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panels A and B) but also 1.8–2.2-fold for Galnac4st1 and
4.6–5.8-fold for St6gal1 as compared with either of the sin-
gle knock-out mice (Fig. 7, panels A and B). Loss of clearance
by the ManR, the ASGR, or both receptors in double knock-
out mice resulted in a small but significant decrease in
B4galnt3 or B4galnt4 transcript levels (Fig. 7, panels C and
D). The pituitary contains multiple different cell types, so the
changes seen in transcript levels may be far greater for these
transferases in the specific cell types that synthesize LH,
TSH, and FSH. Changes in the relative levels of LH and TSH,
as well as their modifying enzymes GalNAc-4-ST1 and
ST6Gal1, could alter the pattern of LH and TSH glycan ter-
minal modification with SO4 and sialic acid and thus have an
impact on clearance rates in vivo.
We examined the testis, a target tissue for LH action, for
changes in transcript levels of genes that would be relevant to
testosterone production, because Leydig cells in the testes
respond to increased LH levels by increasing testosterone pro-
duction. Steady state transcript levels for the LH receptor, ste-
roidogenic acute regulatory protein (StAR), 20-hydroxys-
teroid dehydrogenase (20HSD), activin, and inhibin were
determined in WT, Mrc1/, Asgr2/, and Mrc1/
Asgr2/ mice to see whether there were any changes consis-
tent with LH-driven increases in testosterone production (Fig.
8). There was little change in transcript levels for any of these
genes in eitherMrc1/ or Asgr2/mice compared withWT
mice; however, there was a striking increase in the transcript
levels for each of these genes in Mrc1/Asgr2/ mice. Par-
ticularly notable were the increased levels of mRNA for 20-
hydroxysteroid dehydrogenase (14-fold), activin (4-fold), and
inhibin (6-fold). In Mrc1/Asgr2/ mice, these substantial
increases in testicular components of the testosterone syn-
thetic pathway and regulatory proteins, coupled with ele-
vated circulating testosterone levels and a major decrease in
LH mRNA (Fig. 6, panel A), underscore the more wide-
spread disruption of reproductive hormone homeostasis
that occurs when both major glycan-mediated recognition
and clearance pathways are ablated.
Circulating Glycoproteins Elevated in Pregnant Asgr2/
Mrc1/Mice—BecauseAsgr2/Mrc1/micewere not able
to initiate parturition, we utilizedmass spectrometry to analyze
the plasma fromAsgr2/Mrc1/ andWTmice on 18.5 d.p.c.
FIGURE 5. LH and testosterone but not FSH are elevated inMrc1/, Asgr2/, andMrc1/Asgr2/mice. Plasma was collected from adult male WT,
Mrc1/, Asgr2/, and Mrc1/Asgr2/ mice. Circulating LH levels (panel A) were determined using an immunoradiometric assay and analyzed using a
parametric t test. LH levels were significantly elevated in all three genotypes comparedwithWT (p 0.005). Testosterone levels (panel B) were determined by
RIA and analyzed using a non-parametric t test, Mann-Whitney, because testosterone does not follow a normal distribution. Testosterone was significantly
elevated in all threegenotypes comparedwithWT (p0.05). FSH levels (panel C)weredeterminedbyRIA. Therewasno significant differencebetweenWTand
any of the genotypes. Seminal vesicles (panel D) were dissected andweighed. Seminal vesicle size was determined by testosterone level andwas significantly
increased in all three genotypes: p 0.006 forMrc1/, p 0.002 for Asgr2/, and p 0.02 forMrc1/Asgr2/mice.
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of pregnancy for altered levels of circulating proteins thatmight
be contributing to this condition. At least 90 plasma proteins
were elevated 2.0-fold or more in Asgr2/Mrc1/ as com-
pared with WT mice (supplemental Table I). Among the pro-
teins for which 5 spectra were obtained from Asgr2/
Mrc1/mice, there were 28 instances where no spectra were
obtained from the WT mice indicating concentrations below
the level of detection by mass spectrometry. Forty proteins
were elevated 3.0-fold and an additional 22 were elevated
between 2.0- and 3.0-fold in Asgr2/Mrc1/ compared with
WTmice. Proteins that were elevated included pregnancy-spe-
cific glycoproteins (PSGs), coagulation factors, lysosomal pro-
teins, and collagens. A large number of plasma proteins were
not significantly elevated in Asgr2/Mrc1/ as compared
withWTmice. Among themwere acute phase proteins such as
C-reactive protein and ceruloplasmin, indicating that pregnant
Asgr2/Mrc1/mice did not show evidence of a generalized
increase in inflammatory response as comparedwithWTmice.
The large number of different glycoproteins that are elevated in
Asgr2/Mrc1/mice indicates that theASGR and theManR
contribute to the regulation of a wide range of glycoproteins. It
is likely that the clearance of many additional proteins is also
controlled by the ASGR and theManR, but even when elevated
in Asgr2/Mrc1/mice, their levels fall below that required
for detection by mass spectrometry.
Mass spectrometry indicated that multiple PSGs were ele-
vated in the plasmaofAsgr2/Mrc1/ as comparedwithWT
mice (Table 1). To confirm that circulating PSG23was elevated
in Asgr2/Mrc1/ mice and to determine which receptor
accounted for the clearance of PSG23, we performed Western
blot analyses using plasma fromWT, Asgr2/,Mrc1/, and
Asgr2/Mrc1/ mice. PSG23 was detected in the plasma of
Asgr2/Mrc1/ and Asgr2/ mice but not in the plasma
from either WT or Mrc1/ mice (Fig. 9, panels A and C).
Prolonged exposure of the Western blot did not reveal any
PSG23 in the plasma ofWTandMrc1/mice (Fig. 9, panel C).
In contrast, extracts of placenta fromWT,Asgr2/,Mrc1/,
and Asgr2/Mrc1/ mice contained similar amounts of
PSG23 (Fig. 9, panel B). Thus, the absence of PSG23 in plasma
ofWT andMrc1/mice reflects rapid clearance by the ASGR
rather than a change in PSG23 protein production in its placen-
tal source.
To obtain an indication of the capacity and efficiency of the
ASGR for clearing glycoproteins bearing its recognized glycans,
we determined how much PSG23 was present in the plasma
from WT and Asgr2/Mrc1/ mice. Quantitative Western
blot analyses comparing dilutions of known quantities of
recombinant PSG23 with PSG23 in the plasma of Asgr2/
Mrc1/ mice revealed that the amount of PSG23 in WT
plasmawas less than 50 ng/ml, whereas the amount of PSG23 in
Asgr2/Mrc1/ plasma was in the range of 1–10 mg/ml
plasma. The ASGR is therefore able to reduce the concentra-
tion of PSG23 from 10mg/ml found in the absence of clearance
in Asgr2/Mrc1/ double knock-out or Asgr2/ single
knock-out to less than 50 ng/ml in WT mice.
PSG23 is extensively glycosylated with seven N-glycans that
are distributed over three Ig motifs (42). The elevated levels of
circulating PSG23 and other PSGs seen in Asgr2/ and
FIGURE6. LH, TSH, andFSHmRNA levels are altered in thepituitaries
of Mrc1/, Asgr2/, and Mrc1/Asgr2/ mice. Pituitaries were col-
lected from adult male WT (n  7), Mrc1/ (n  7), Asgr2/ (n  7), and
Mrc1/Asgr2/ (n 5) mice, and the relative quantity of mRNAwas deter-
mined by PCR. mRNA levels differed significantly from those of WT mice as
follows: panel A, LH inMrc1/ (p 0.02);Asgr2/ (p 0.0001); andMrc1/
Asgr2/ (p 0.006) mice. Panel B, TSH in Asgr2/ (p 0.04) andMrc1/
Asgr2/ (p 0.0001)mice, and panel C, FSH inMrc1/Asgr2/ (p 0.01)
mice.
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Asgr2/Mrc1/mice but not in WT orMrc1/mice indi-
cated that PSGs bear glycans that are recognized by the ASGR,
for example, N-linked glycans terminating with either
Gal1,4GlcNAc or GalNAc1,4GlcNAc as well as glycans ter-
minating with Gal1,4[Fuc1,3]GlcNAc known as Lewisx or
GalNAc1,4[Fuc1,3]GlcNAc (see Fig. 1) (9, 43). During gly-
can synthesis, terminal 1,4-linked Gal or GalNAc is typically
further modified with sialic acid or in the case of GalNAc with
SO4; however, the presence of Fuc on the underlying GlcNAc
prevents the addition of sialic acid. In a recent study, we utilized
recombinant PSG23 bearing each of the N-glycans shown in
Fig. 1 to demonstrate that the ASGR mediated clearance of
PSG23 bearing glycans terminating with either 1,4-linked Gal
orGalNAc in the presence or absence of an underlying Fuc, and
that the addition of either sialic acid or sulfate prevented clear-
ance by the ASGR (9).
Immobilized plant lectins can be utilized to differentiate
amongmany of theN-glycan structures shown in Fig. 1 (44, 45)
as summarized in Fig. 10. To gain insight into the structure of
theN-glycans on endogenous PSG23, we compared the behav-
ior of PSG23 present in the plasma of Asgr2/Mrc1/ mice
with that of recombinant PSG23 bearing glycans of known
structure during digestion with glycosidases of known specific-
ity and during lectin affinity chromatography. Wisteria flori-
bunda agglutinin (WFA) binds glycans with terminal 1,4-
linked GalNAc but not those with 1,4-linked Gal, whereas
Ricinus communis agglutinin-I (RCAI) binds glycans with ter-
minal 1,4-linked Gal but not those with 1,4-linked GalNAc
(45–48). PSG23 from Asgr2/Mrc1/ mice was bound by
RCAI-agarose but not by WFA-agarose (Fig 10, panel C), indi-
cating that terminal 1,4-linked Gal but not GalNAc was pres-
ent on itsN-glycans. It should be noted that glycoproteins such
as PSG23 modified with multiple N-glycans are not readily
eluted from the immobilized lectin using competitivemono- or
disaccharides. The bound PSG23 can, however, be eluted by
boiling in loading buffer for SDS-PAGE. The binding can be
demonstrated to be lectin-dependent by incubation with the
immobilized lectin in the absence or presence of lactose that
prevents binding (see Fig. 10, panel E, for example).
Binding of PSG23 by immobilized RCAI but not WFA indi-
cated that terminal 1,4-linked Gal rather than GalNAc was
present on the PSG23N-glycans.Digestionwith neuraminidase
resulted in a small shift in themobility of PSG23 that can be best
appreciated in Fig. 10, panel B, indicating a small amount of
terminal sialic acid was present. However, following digestion
with neuraminidase, binding to immobilized WFA and RCAI
was unchanged (Fig. 10, panel D) indicating that neither 1,4-
linked GalNAc nor Sia2,6GalNAc was present.
FIGURE 7. Galnac4st1, St6gal, B4galnt3, and B4galnt4 mRNA levels are altered in the pituitaries ofMrc1/, Asgr2/, andMrc1/Asgr2/mice.
Pituitaries were collected from adultmaleWT (n 7),Mrc1/ (n 7), Asgr2/ (n 7), andMrc1/Asgr2/ (n 5)mice, and the relative quantity ofmRNA
was determined by PCR. mRNA levels differed significantly from those of WT mice as follows. Panel A, galnac4st1 in Mrc1/ (p 0.0001) and Asgr2/ (p
0.001) mice. Panel B, St6gal1 inMrc1/ (p 0.0002), Asgr2/ (p 0.002), andMrc1/Asgr2/ (p 0.0001) mice. Panel C, B4galnt3 forMrc1/ (p 0.01)
and Asgr2/ (p 0.02) but notMrc1/Asgr2/mice. Panel D, B4galnt4 forMrc1/ (p 0.007) andMrc1/Asgr2/ (p 0.004) but not Asgr2/mice.
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Clearance by the ASGR and binding by immobilized RCAI
indicated the presence of 1,4-linked Gal. However, digestion
with -galactosidase did not alter the migration of endogenous
PSG23 on SDS-PAGE (Fig. 10, panels A and B) or binding by
immobilized RCAI (Fig. 10, panels A, B, and E). The -galacto-
sidase produced by Diplococcus pneumoniae is highly specific.
This enzyme releases the 1,4-linked Gal from Gal1,4GlcNAc
but not from the LewisX structureGal1,4[Fuc1,3]GlcNAc, as
we previously confirmed with recombinant PSG23. In those
studies, binding of recombinant PSG23 bearing Gal1,
4GlcNAc to RCAI-agarose was abolished by digestion with dip-
lococcal -galactosidase, whereas binding of recombinant
PSG23 bearing LewisX structure Gal1,4[Fuc1,3]GlcNAcwas
not affected by digestion with diplococcal -galactosidase (9).
Thus, it is likely that the endogenous PSG23 analyzed here
bears the LewisX structure. Multiple monoclonal antibodies
specific for the LewisX structure from commercial sources and
generously provided by colleagues (49) were tested as potential
FIGURE 8.Alterations in LH receptor, steroidogenic acute regulatory protein, 20-hydroxysteroid dehydrogenase, activin, and inhibinmRNA levels
in the testes ofMrc1/, Asgr2/, andMrc1/Asgr2/mice. Testes were collected from adult male WT (n 4),Mrc1/ (n 4), Asgr2/ (n 4), and
Mrc1/Asgr2/ (n 4) mice, and the relative quantity of mRNAwas determined by PCR. mRNA levels differed from those ofWTmice as follows. Panel A, LH
receptor (LHR) in Mrc1/Asgr2/ (p  0.005) mice but not in Mrc1/ or Asgr2/ mice. Panel B, StAR in Mrc1/Asgr2/ (p  0.0002) mice but not in
Mrc1/ or Asgr2/ mice. Panel C, 20HSD in Mrc1/ (p  0.001) and Mrc1/Asgr2/ (p  0.0001) mice but not Asgr2/ mice. Panel D, activin in
Mrc1/Asgr2/ (p 0.002) mice but not in eitherMrc1/ or Asgr2/mice. Panel E, inhibin inMrc1/ (p 0.05) andMrc1/Asgr2/ (p 0.0008) mice
but not Asgr2/mice.
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probes for the LewisX structure on N-linked glycans using our
recombinant PSG23 known to bear this structure. Whereas
some monoclonals (49) were active against the LewisX struc-
ture on O-linked glycans, none were active against the LewisX
structure on N-linked glycans; thus, these reagents were not
usable for analyzing the LewisX structure on endogenous
PSG23. Digestion of plasma with endoglycosidase H did not
change the mobility of PSG23 (Fig. 10, panel A) indicating no
oligomannose structures were present. Digestion with protein
N-glycanase resulted in a shift from 75 to 50 kDa consistent
with the presence of 7N-glycans (Fig 10, panel A). The decrease
in intensity upon Western blot analysis reflects increased sen-
sitivity to degradation by plasma proteases following removal of
the N-glycans. The properties of PSG23 summarized in Fig. 10
suggest that the PSGs produced during pregnancy bear glycans
extensively modified with the LewisX structure Gal1,4[Fuc1,3]
GlcNAc that cannot accept the addition of sialic acid. This gly-
can would thus remain uncapped, ensuring its clearance by the
ASGR when released into the circulation in mice expressing a
full complement of the ASGR and promoting a highly localized
site of action for PSG23 at the fetoplacental unit.
Additional glycoproteins were elevated in the plasma of
Asgr2/Mrc1/ mice, including coagulation factors, colla-
gens, lysosomal enzymes, and others. Eight different collagen 
chains were elevated in the plasma ofAsgr2/Mrc1/ (Table
1). The fibronectin type II domain of the ManR binds collagen
(50), and two previous studies have also implicated theManR in
turnover of collagen in vivo (51, 52). For some proteins, the
number of spectra obtained for elevated proteins in the double
knock-out mice was not sufficient to be considered significant;
i.e. 5, even though no spectra were obtained for those same
proteins fromWTplasma. Thiswas true for lysosomal enzymes
that have previously been reported to be elevated in Mrc1/
mice (21) and for a number of coagulation factors. Thus, even
when their levels were actually elevated, many proteins were
not present in sufficient quantity to provide5 spectra unless
enriched to an even greater extent than was done for these
studies. The number and fold elevation for circulating glyco-
proteins due to ablation of both the Man and the ASGR may
thus be considerably greater than is indicated by the results in
Table 1 and supplemental Table I.
The priapism seen inmaleAsgr2/Mrc1/mice as a result
of thrombosis of the penile vein could result from increased
levels of certain coagulation factors; for example, vWF has pre-
viously been reported to be elevated inAsgr2/mice (16).We
confirmed that vWF levels were elevated in Asgr2/Mrc1/
TABLE 1
Selected groups of plasma proteins elevated on 18.5 d.p.c. of pregnancy inMrc1/Asgr2/mice
INF, infinite.
Protein Accession no. Molecular mass -Fold change WT KO
kDa
CEA-related
PSG27 Q497W2 54 51 2 101
PSG30 (CEACAM5) Q3UKK2 106 90 1 87
PSG23 Q9D2UO 53 22 3 66
PSG21 Q9DAV5 53 21 2 42
CEACAM12 Q3UKP4 34 13 2 25
CEACAM11 Q9D0Z8 34 INF 0 17
PSG16 Q8KOU8 45 27 1 14
CEACAM14 Q78Y72 29 INF 0 6
PSG28 Q4KL66 53 INF 0 2
PSG18 B2RSG7 54 INF 0 1
Coagulation
VonWillebrand factor Q8CIZ8 309 7.0 1 7
Coagulation Factor XIIIA Q8BH61 83 6.8 4 27
Coagulation Factor V O88783 247 2.2 81 178
Transforming growth factor--induced protein ig-h3 P82198 75 12 1 12
Platelet glycoprotein V (fragment) Q9QZU3 63 INF 0 6
Platelet glycoprotein 1b  chain O35930 80 3.7 6 22
Platelet-activating factor acetylhydrolase Q60963 49 3.1 12 37
Thrombospondin-4 Q9Z1T2 106 INF 0 30
Collagens
Collagen -1(VI) chain Q04857 108 INF 0 33
Collagen -2(V) chain Q3U962 145 INF 0 19
Collagen -1(V) chain O88207 184 INF 0 15
Collagen -1(XI) chain Q61245 181 INF 0 14
Collagen -2(XI) chain Q64739 172 INF 0 6
Collagen -1(I) chain P11087 138 3.5 10 35
Collagen -2(I) chain Q01149 130 3.4 7 24
Collagen -1(III) chain P08121 139 2.2 5 11
Lysosomal proteins
N-Acetylgalactosamine-6-sulfatase Q571E4 58 INF 0 15
-Interferon-induced lysosomal thiol reductase Q9ESY9 28 INF 0 6
-Hexosaminidase subunit  P20060 61 INF 0 4
Lysosomal Pro-X carboxypeptidase Q7TMR0 55 INF 0 4
Lysosomal acid lipase/cholesterol ester hyrolase Q9Z0M5 45 INF 0 3
Cathepsin D P18242 45 4.0 3 12
Lysosomal -mannosidase O09159 115 1.7 14 24
Miscellaneous
Serum amyloid P-component P12246 26 3.3 39 129
C-reactive protein P14847 25 1.0 39 39
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mice via Western blot analysis and by immunoassay (Fig. 11).
vWFwas elevated inmalemice, in both those that did and those
that did not exhibit priapism (Fig. 11, panel C). Comparing the
levels of circulating vWF in pregnant and non-pregnant female
Asgr2/Mrc1/mice revealed that the level of elevation and
fraction of mice that had elevated levels was greater for preg-
nant than non-pregnant mice (Fig. 11, panels B and C). In con-
trast, there was no significant difference in vWF levels among
pregnant and non-pregnant WT mice. In addition to vWF,
coagulation Factor V was elevated 2.2-fold, and Factor XIIIA
was elevated 6.8-fold in Asgr2/Mrc1/ pregnant mice
(Table 1 and supplemental Table I). Elevated levels of vWF,
Factor V, Factor XIIIA, transforming growth factor 1-induced
protein ig-h3 (TGFBIp/ Ig-h3), and a number of platelet gly-
coproteins suggest a generalized hypercoagulable state in dou-
ble knock-outmice that could increase the probability of penile
vein thrombosis in male mice during the stasis that occurs dur-
ing erection.
Discussion
Ever since we characterized the unique N-glycans shown in
Fig. 1 that terminate with 1,4-linked GalNAc-4-SO4 on the
glycoprotein hormone LH (37–40), we have sought to under-
stand the biological function of these structures. Using geneti-
cally manipulated mice, we here demonstrate that clearance of
endogenous LH is mediated by theManR. In earlier studies, we
demonstrated that LH and other glycoproteins bearing termi-
nal 1,4-linked GalNAc-4-SO4 are rapidly removed from the
circulation by a receptor expressed by SECs that we identified
as a dimeric form of the ManR (1, 22–24). Terminal GalNAc-
4-SO4 is bound by the cysteine-rich domain located at the N
terminus of the ManR, and the bound glycoprotein is rapidly
internalized (25, 26). We proposed that rapid clearance of LH
by theManR is required to generate the episodic rise and fall of
LH seen in vivo following its regulated release from the pituitary
that is required for optimal production of estrogen in the ovary.
We provided support for this proposed role for theManR by
ablating GalNAc-4-ST1, the sulfotransferase that mediates sul-
fate addition to 1,4-linked GalNAc on N-linked glycans (Fig.
1). In the absence of GalNAc-4-ST1 activity, the SO4 on Gal-
NAc was replaced by 2,6-linked sialic acid. The half-life of
endogenous LH inGalNAc-4-ST1 knock-out mice bearing this
modified glycan structure was thereby increased, resulting in
increased LH and estrogen/testosterone levels, premature sex-
ual maturation, and enlarged uteri/seminal vesicles. These
phenotypic alterations clearly supported the importance of
pituitary glycoprotein hormone clearance on the basis of Gal-
NAc-4-SO4 (32). More recently, we reported that levels of
ManR expression during pregnancy are regulated by progester-
one, rising to maximum levels by 17 d.p.c. before beginning to
decline. Furthermore,Mrc1/mice lose the ability to rapidly
remove recombinant PSG23 bearing N-glycans terminating
with GalNAc-4-SO4 from the circulation (9).
Our current demonstration that clearance rates are pro-
longed for endogenous LH in both Asgr2/Mrc1/ and
Mrc1/ mice but not in Asgr2/ mice, compared with WT
mice, establishes that theManR regulates the clearance rate for
endogenous LH on the basis of its sulfateN-linked glycans. Like
GalNAc-4-ST1/ mice (32), Mrc1/ male mice display
increased levels of circulating LH and testosterone and
enlarged seminal vesicles, a biological indicator of enhanced
testosterone levels. Thus, the prolonged half-life seen for
endogenous LH inMrc1/male mice results in physiological
changes that are similar to those seen in GalNAc-4-ST1/
mice, further demonstrating the importance of the ManR in
regulating LH function.
The ASGR mediates the rapid clearance of glycoproteins
bearing glycans with terminal Gal or GalNAc (Fig. 1); however,
the presence of SO4 on the GalNAc of LH glycans prevents
recognition by the ASGR. Thus, endogenous LH is cleared nor-
mally in Asgr2/mice. Nonetheless, expression of the ASGR,
like that of theManR, is regulated during pregnancy by proges-
terone (9), suggesting it may have a role during pregnancy.
Remarkably, in the absence of clearance of ASGR-recognized
structures in Asgr2/male mice, circulating levels of LH and
testosterone are elevated, and seminal vesicle size is increased.
Therefore, the ASGR contributes to the regulation of LH levels
and as a consequence to testosterone levels in vivo. Male
Asgr2/mice were fertile and did not display an obvious func-
tional phenotype.
In contrast to male Asgr2/ mice, female Asgr2/ mice
had a spontaneous functional phenotype comprising altered
parameters of reproduction. Thirty five percent of female
Asgr2/ mice did not initiate parturition the evening of
FIGURE 9. PSG23 is elevated during pregnancy in Asgr2/Mrc1/ and
Asgr2/mice. Panel A, plasma proteins, 25g/lane, frompregnantmice on
day 18 (P18), day 19 (P19), and day 21 (P21) were subject to SDS-PAGE using
4–14% gradient gels under reducing conditions. The proteins were electro-
phoretically transferred to PVDF membranes and subject to Western blot
analysis using rat anti-mouse PSG23. Lanes labeled WT were from wild type
mice; lanes labeled KOwere from Asgr2/Mrc1/ double knock-out mice;
and lanes labeledAsgr2/orMrc1/were from singleAsgr2/orMrc1/
knockouts, respectively. Staining of the PVDF followingWestern blot analysis
demonstrated that protein loads were equal. Panel B, placenta proteins from
day 18 of pregnancy were solubilized using T-PER (Pierce) and 25 g of pro-
tein per lane was subject to SDS-PAGE using 4–14% gradient gels under
reducing conditions. The proteins were electrophoretically transferred to
PVDF membranes and subjected to Western blot analysis using rat anti-
mouse PSG23. Panel C, plasma from the mice analyzed in panel B was exam-
ined by SDS-PAGE followed by Western blot using rat anti-mouse PSG23.
Arrowheads indicate the location of a 75-kDa standard and the bar a 50-kDa
standard.
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d.p.c.19 and expired attempting to deliver post-mature pups.
The fraction of mice unable to initiate parturition the evening
of d.p.c.19 increased to 61% in Asgr2/Mrc1/ female
mice. Thus, the inability to initiate parturition reflects primarily
the lack of circulating glycoprotein clearance by the ASGR and
is amplified by the additional of loss of clearance by the ManR.
Because clearance by both the ManR and the ASGR has an
impact on LH levels, and expression of both receptors is regu-
lated by progesterone over the course of pregnancy, the pheno-
type of Asgr2/Mrc1/ mice indicates that the ASGR and
theManR together play a critical role in regulating the initiation
of parturition. Falling levels of progesterone contribute to the
initiation of parturition in mice. RU486, a progesterone homo-
logue that acts as a progesterone receptor antagonist and inter-
feres with endogenous progesterone action, will induce prema-
ture parturition in mice. RU486 induced parturition in both
WT andMrc1/mice. In contrast, RU486 was not effective in
initiating parturition in Asgr2/Mrc1/ mice and was only
partially effective in Asgr2/ mice. The resistance to RU486-
induced parturition suggested that abnormal progesterone reg-
ulation alone was not the basis for the inability to initiate par-
turition at the proper time. The absence of pubic symphysis
FIGURE 10.Characteristics of PSG23glycans fromcirculatingPSG23 inAsgr2/Mrc1/mice. Left, top, schematic of glycan structures thatwegenerated
on recombinant PSG23. Left, bottom,behavior of each versionof PSG23bearing the illustratedglycan structure,when incubatedwith immobilizedWFAorRCAI
is denoted asbound () or unbound ().Right, upper box, key toglycan structure components shownat left. Right, lower box,behavior of PSG23 inplasma from
Asgr2/ Mrc1/ mice. Panels A and B, plasma containing endogenous PSG23 was incubated in buffer () or digested () with neuraminidase (Nase),
diplococcal -galactosidase (Gal) with the specificity indicated, endoglycosidase H (Endo H), or protein N-glycanase (PNGase). Western blot analysis using
anti-PSG23 following SDS-PAGE is shown. The location of 75- and 50-kDa standards is indicated. Panel C,plasma containing PSG23. Panel D,plasma containing
PSG23 digested with neuraminidase was incubated with immobilizedWFA, RCAI, or unsubstituted agarose (AGAR). Aliquots of the unbound fraction (UB), the
material eluted with GalNAc and lactose, respectively (panel E), and of material eluted by boiling the immobilized lectin in SDS-PAGE loading buffer (panel B)
were subjected toWestern blot analysis. Pl indicates an aliquot of plasma equal to that of theUB, E, and B fractions examined. Panel E, following digestionwith
diplococcal-galactosidase (Gal) plasmawas incubated the immobilizedRCAI-agarose in theabsence () orpresence () of lactose. TheUB, E, andB fractions
were analyzedbyWestern blottingwith anti-PSG23 after SDS-PAGE. The plasma containing endogenous PSG23was incubatedwith immobilizedWFAor RCAI,
and the amount of PSG23 present in the UB, E, and B fractions were determined by Western blot analysis following SDS-PAGE. PSG23 was also digested with
neuraminidase (x Nase) or neuraminidase followed by diplococcal-galactosidase (xGal) with the specificity indicated, prior to incubationwith immobilized
lectins. The properties of the PSG23 in the plasma from Asgr2/ Mrc1/ mice suggests that the predominant glycan structure on PSG23 is the Lewisx
structure shown.
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widening also suggested that multiple aspects of the process
leading to parturition were abnormal in Asgr2/Mrc1/
mice.
The changes seen in Mrc1/, Asgr2/, and Mrc1/
Asgr2/mice indicate that both theManR and theASGR con-
tribute to regulation of the hypothalamus-pituitary-gonad axis.
The elevated levels of LH and testosterone seen in Asgr2/
mice suggest that a glycoprotein bearing a specific structure
that would cause it to normally be cleared from the circulation
by the ASGR acts as a positive regulator of LH levels in vivo.
Testosterone and estrogen are negative regulators of LH levels.
In contrast to testosterone and estrogen, this as yet unidentified
glycoprotein cleared by the ASGR stimulates LH production.
Our findings point to both positive and negative regulation of
LH production and release by the pituitary on the basis of gly-
can structures. The increase in LH and testosterone seen in
Asgr2/Mrc1/micewas not greater than that seen in either
Asgr2/ orMrc1/mice, suggesting that the inhibitory feed-
back effect of testosterone on LH production and release may
dominate over positive regulation mediated via the unknown
glycoprotein cleared by theASGR. The decrease in LHmRNA
levels seen in the pituitaries ofAsgr2/Mrc1/mice, as com-
pared with the increases seen in both Asgr2/ and Mrc1/
mice (Fig. 6), could also reflect dominance of negative regula-
tion by testosterone. We would not have been able to identify a
role for a positive glycoprotein regulator of LH levels without
the double knock-out of both the ManR and the ASGR.
The marked elevation of steady state transcript levels for
20HSD, StAR, activin, inhibin, and LHR in the testis of
Asgr2/Mrc1/ mice, as compared with either Asgr2/ or
Mrc1/ mice, provides further evidence that two different
forms of regulation are being exerted by the ManR and ASGR.
The 10-fold elevation of 20HSD transcript in the testis of
Asgr2/Mrc1/mice may serve to mute elevation of testos-
terone that would otherwise be even greater, because the pro-
gesterone is being converted to an inactive precursor. We have
shown that ASGR expression is regulated by progesterone in
pregnant mice and is maximal around 17 d.p.c. of pregnancy
(9). Lack of clearance of glycans recognized by the ASGR in
both Asgr2/ and Asgr2/Mrc1/ mice at this point in
pregnancy may disrupt the regulation of estrogen and proges-
terone levels critical for the initiation of parturition. This dis-
ruption would be further amplified by a lack of LH clearance by
the ManR, potentially accounting for greater penetrance of the
inability to initiate parturition in Asgr2/Mrc1/ mice as
compared withAsgr2/mice. Additional glycoproteins exert-
ing a direct effect on initiating parturition may also be elevated
in the absence of clearance by the ASGR.
The remarkable numbers and types of glycoproteins elevated
in the blood of pregnant Asgr2/Mrc1/ mice indicate that
theASGR and theManR together regulate the circulating levels
of many different glycoproteins. Certain glycoproteins that are
known to be elevated inMrc1/mice, for example many lys-
osomal enzymes (21), were not detected by ourmass spectrom-
etry strategy, most likely because they remain below the level
required for detection. As a consequence, the list of glycopro-
teins whose concentration is regulated by the ASGR and/or the
ManRmay be considerably larger than that indicated in supple-
mental Table I. Because of the massive levels of ASGR and
ManR expressed in the liver and their rapid rates of endocytosis
and recycling to the cell surface, both receptors can reduce the
FIGURE 11. von Willebrand factor is elevated in Asgr2/ Mrc1/mice.
Plasma was obtained fromWTmale mice, Asgr2/Mrc1/male mice with
and without priapism, WT female mice, Asgr2/ Mrc1/ female mice, WT
pregnant female mice on P18, and pregnant Asgr2/Mrc1/ female mice
on P18 (n 11 for each group). The amount of vWFwas determined by ELISA
asdescribed.Panel A shows thevalues for individualmalemiceandpanel B for
individual female mice (70, 71). Panel C shows the mean and S.E. for each
group. p values were determined using Mann-Whitney t test as follows: WT
male versus Asgr2/ Mrc1/ male without priapism p  0.004; WT male
versus Asgr2/ Mrc1/ male with priapism p  0.013; Asgr2/ Mrc1/
male with priapism versus without priapism p  0.41; WT versus Asgr2/
Mrc1/ non-pregnant female p  0.19; WT versus Asgr2/ Mrc1/ preg-
nant female on P18 p  0.0001; and WT versus Asgr2/ Mrc1/ pregnant
females on P18 0.047.
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circulating quantities of glycoproteins that each recognizes to
undetectable levels in a single pass through the liver.
PSG23 is illustrative of the capacity of the ASGR for clear-
ance of circulating glycoproteins. In the absence of clearance by
the ASGR, PSG23 reaches circulating levels of 10 mg/ml, yet it
occurs at50 ng/ml inWTmice. PSG23 is only onemember of
a family of multiple PSGs as well as other glycoproteins that are
elevated in the absence of glycan-directed clearance by the
ASGR. Thus, the capacity of the ASGR receptor to clear glyco-
proteins from the blood is truly remarkable.
Elevation of PSG23 and other PSGs was one of the most
striking changes associatedwith the absence of clearance by the
ASGR. The family of 17 psg gene products in mice is expressed
by trophoblast giant cells and spongiotrophoblasts in the pla-
centa over the course of pregnancy (33, 34, 42). The PSGs are
extensively modified with N-glycans. PSG23 induces trans-
forming growth factor1 (TGF1) bymacrophages, inhibits the
interaction of platelets with fibrinogen, and induces endothelial
tube formation in vitro (53), likely playing a role in vascular
remodeling and immune regulation at the fetus-placenta inter-
face (54–56). Remarkably, a target of the TGF1 pathway,
namelyTGFBIp/ Ig-h3, is elevated 12-fold in the circulation of
pregnant Asgr2/Mrc1/ mice (see Table 1). This suggests
that PSG23 may be driving elevated levels of transforming
growth factor 1 in pregnant Asgr2/Mrc1/. Although
characteristic of pregnancy, the precise function of PSG23 and
the other murine PSGs in vivo remains unknown. The fact that
PSGs are reduced to undetectable levels in WT mice suggests
that their function in vivo is localized to the fetus-placenta
interface, as they are rapidly cleared when they enter the blood.
Thrombosis of the penile vein and the resulting priapism
seen in 25% ofAsgr2/Mrc1/mice indicated imbalances in
coagulation. The coagulation factors vWF, Factor XIIIA, and
Factor V, along with a number of platelet proteins, were among
the circulating proteins elevated in Asgr2/Mrc1/ mice
(Table 1 and supplemental Table I). vWF has previously been
reported by Marth and co-workers (16) to be elevated in
Asgr2/ mice. We found that vWF was elevated in double
knock-outmales with andwithout priapism as well as in double
knock-out females. The range of values seen for elevated vWF
among individual animals was large (Fig. 11). vWF, stored in
Weibel-Palade bodies of the endothelial cell, is released in
response to endothelial cell injury and initiates coagulation by
binding to exposed collagen (57). The markedly elevated levels
of vWF seen among individual mice may reflect regulated
release due to recent endothelial injury. It is possible that a large
fraction of the vWF inWeibel-Palade bodies bears glycans that
are normally recognized by the ASGR, causing this component
of the vWF pool to be rapidly cleared inWTmice so as to limit
coagulation to the site of release. The vWF remaining in the
plasma ofWT animals would in this case represent a fraction of
material that is not rapidly cleared, potentially accounting for
the long half-life that has been reported for vWF isolated from
plasma (58, 59). Because vWF was elevated in males with and
without priapism, it is not likely to alone account for the throm-
bosis of the penile vein.
Coagulation Factor V in humans and TGFBIp/ Ig-h3 in
mice are associatedwith pulmonary embolismdue to thrombus
formation (60–63) and are elevated in plasma from Asgr2/
Mrc1/ pregnant female mice (Table 1 and supplemental
Table I). Following its activation, Factor V in humans acceler-
ates thrombus formation during the conversion of prothrom-
bin to thrombin. Activated Factor V is in turn inactivated by a
serine protease termed activated protein C. A human mutant
form of Factor V, Factor V Leiden, is resistant to proteolytic
inactivation by activated protein C, resulting in increased
amounts of circulating activated Factor V Leiden and an
increased risk of venous thrombosis (61–63). Similarly
increased levels of activated Factor V in Asgr2/Mrc1/
male mice, reflecting a lack of clearance of this coagulation
factor, could result in thrombosis of the penile vein due to
venous stasis during erection. TGFBIp/ Ig-h3, a matrix pro-
tein that may promote platelet adhesion, is also associated with
thrombus formation (60). Transgenic mice with a 1.7-fold
increase in circulating TGFBIp/ Ig-h3 are more susceptible to
formation of collagen-induced pulmonary emboli (60). Thus,
elevated levels of Factor V and/or TGFBIp/ Ig-h3 may con-
tribute to thrombus formation in the penile vein. Because pri-
apism was only observed in Asgr2/Mrc1/ male mice, it
would appear that proteins cleared by both receptors contrib-
ute to the increased risk of thrombosis in these mice.
Our studies here demonstrate that the ASGR and the ManR
play a much broader role in regulation of the circulatory half-
lives of a wide range of plasma glycoproteins than has previ-
ously been appreciated. The high expression levels of these
receptors and their rapid rate of internalization, in combination
with the large number of PCs and SECs that make up the liver,
result in an enormous capacity for clearance of glycoproteins.
Reducing the concentration of circulating glycoproteins bear-
ing glycans recognized by theASGR and theManR to undetect-
able levels may serve to prevent harmful effects, for example
from activated coagulation factors or lysosomal enzymes. The
receptors also determine the circulatory half-life of other gly-
coproteins such as the glycoprotein hormone LH following its
regulated release by cells in the pituitary (9, 23, 32). The ASGR
and the ManR are multifunctional entities by virtue of the gly-
coproteins that they recognize and the manner in which they
remove them from the circulation. The ASGR and the ManR
play critical roles in reproduction by regulating hormonal lev-
els. Defining precisely how they accomplish thiswill lead to new
insights that may allow us to better predict and control the
process of parturition and other aspects of reproduction. The
translational implications of our work point toward future
strategies to reduce risk factors associated with pregnancy such
as an increased risk of thrombosis.
Experimental Procedures
Timed Mating—Mrc1/Asgr2/ knock-out mice were
generated and maintained by mating Mrc1/Asgr2/ male
mice withMrc1/Asgr2/ female mice. Female mice mated
overnight with male mice were examined the following morn-
ing for the presence of a vaginal plug; gestational age was des-
ignated as 0.5 d.p.c. for those mice with a vaginal plug. RU486
(mifepristone), a progesterone receptor antagonist (36), was
used to induce preterm labor by injecting pregnant mice sub-
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cutaneously (150 g of mifepristone in 100 l of corn oil con-
taining 10% ethanol) on 15.5 d.p.c.
Serum Collection—Mice were anesthetized with ketamine
(87 mg/kg) and xylazine (13 mg/kg) for terminal blood collec-
tion by cardiac puncture. Blood was allowed to clot for 60 min
at 25 °C and then sedimented for 15min at 25 °C by centrifuga-
tion. The serum was removed and stored at 80 °C until
analysis.
Clearance of Endogenous LH—Male mice were castrated 5
days prior to examining the clearance of endogenous LH as
described previously (32). A 2-cm ventral midline incision was
made in the scrotum of mice anesthetized with ketamine (87
mg/kg) and xylazine (13.4 mg/kg). The tunica was pierced, and
the testis was pushed out by gentle pressure. The spermatic
artery was cauterized and the testis removed. The epididymis,
deferential vessels, and ductus were replaced in the tunica. The
incision was closed with wound clips.
Clearance studies were performed with anesthetized mice.
Following collection of a baseline sample of 150 l of blood,
designated time 0, each mouse was injected intravenously with
10g of acyline (WoodsAssay Inc., Portland,OR) via the lateral
tail vein. Blood (150 l) was drawn retro-orbitally at the times
indicated. After each withdrawal, 200 l of warm saline was
injected into the peritoneum.
HormoneAssays—Quantitation of LH, FSH, and testosterone
was performed by the University of Virginia Center for
Research in Reproduction Ligand Assay and Analysis Core
(Charlottesville, VA).
Histology—Mouse penile tissues were fixed in 10% buffered
formalin overnight at room temperature, embedded in paraffin,
and sectioned. For morphological studies, the slides were
stained with hematoxylin and eosin.
Analysis of mRNA Expression by Real Time Quantitative
PCR—Tissueswere homogenized inTRIzol (Life Technologies,
Inc.) according to the manufacturer’s instructions. RNA purity
and concentration were determined with Nanodrop 2000c
(NanoDrop Products, Wilmington, DE). One microgram of
total RNA was reverse-transcribed using Omniscript reverse
transcriptase (Qiagen, Valencia, CA) in a volume of 20 l using
the protocol supplied by the manufacturer. For real time PCR,
each reaction contained 9 l of cDNA diluted 1:25 in diethyl
pyrocarbonate-treated water, and 10 l of TaqMan Universal
Fast Master Mix (Applied Biosystems), 1 l of primer mix, and
primers were used to perform real time PCR in triplicate using
a StepOnePlus (Applied Biosystems). Melting curve analysis
was performed to confirm the absence of nonspecific product
amplification for each primer set. For quantification, the CT
method (64) was used to determine the relative expression
between groups. The threshold cycle (CT) was determined for
genes of interest and the housekeeping gene Hprt1. The data
were normalized by subtracting theCT for each gene of interest
from the CT for Hprt1 to determine the CT value. After this
loading control correction, the relative expression levels of the
genes of interest in an experimental sample was compared with
that of calibrator sample by subtracting theirCT values. In our
experiments, we used a cDNA pool of all the samples as the
calibrator. By using the same calibrator, the relative expression
for every sample was calculated using the following formula:
relative fold change  2x, where x is the difference between
the CT of the experimental sample and the calibrator sample.
Multiaffinity Fractionation (MAF) of Mouse Plasma—Four
75-l aliquots of plasma from 18.5 d.p.c. WT and Mrc1/
Asgr2/ mice were pooled for analysis. Six highly abundant
proteins were depleted from the pooled samples (albumin, IgG,
IgA, haptoglobin, transferrin, and-1-antitrypsin) by immuno-
affinity chromatography (Agilent Technologies, PaloAlto, CA).
MAFwas performed on a BioCADVisionWorkstation, using a
Cavro AFC 2000 autosampler/fraction collector. The affinity
runs were monitored with a UV detector at 280 nm. For auto-
matedMAF, an equal volume of 2TBS (20mMTris-HCl, 150
mMNaCl, pH 7.4) was added to each of the frozen plasma sam-
ples. After gentle inversion, each sample was filtered through a
0.45-m filter unit (Millipore, Billerica, MA), and an 800-l
aliquot of the filtrate was diluted to 2100 l with 1 TBS. The
diluted sampleswere injected onto the affinity columns froman
autosampler at 4 °C. Bound proteins were eluted from the col-
umnwith 25ml of 100mMglycine buffer, pH2.5, anddiscarded.
The affinity column was then neutralized with 100mMTris-Cl,
pH 8, and re-equilibrated with TBS, pH 7.4. The flow-through
fraction was transferred to a concentrating device (Amicon
Ultra-15, nominal molecular mass cutoff 3 kDa) and centri-
fuged according to manufacturer’s guidelines (4000  g, 4 °C),
reducing the volume to	300 l for subsequent analyses.
Analytical One-dimensional SDS-PAGE—The reproducibil-
ity of automated MAF of the plasma samples was initially eval-
uated using analytical SDS-PAGE. Protein concentrations of
the concentrated depleted plasma samples were determined
using the Advanced Protein Assay reagent (Cytoskeleton, Den-
ver, CO) against a curve made with BSA standard solution
(Pierce), measured at 590 nm. Aliquots of the concentrated
samples, each containing 5g of protein (	10l), were diluted
with 5l of 4 sample buffer (Bio-Rad) and 1l of 20 reduc-
tant (Bio-Rad), heated to 95 °C for 5 min, cooled to room tem-
perature, centrifuged at 13,000 rpm for 30–60 s, and loaded
withmolecular weightmarkers (Bio-Rad Precision Plus Protein
standards, catalogue no. 161-0363) onto 4–12% Criterion XT
BisTris gels. Gels were run in MES buffer, monitored using the
blue dye front, placed in fixative solution (10% methanol, 5%
acetic acid) for 1 h, stained with SyproRuby (Invitrogen) for 2 h,
destained (10% methanol, 5% acetic acid) for 30 min, and
scanned on aTyphoon 9400 scanner (GEHealthcare,UK) using
the following settings: 457 nm excitation, 610BP30 emission
filter, and photomultiplier tube voltage adjusted to stay below
saturation for the darkest band.
Preparation of Peptides from MAF Plasma—The concen-
trated unbound eluates from the multiaffinity columns were
precipitated using the vendor protocol for the two-dimensional
clean-up kit (GEHealthcare). Protein pelletswere solubilized in
20 l of Tris buffer (100 mM, pH 8.5) containing 8 M urea.
Disulfide bonds were reduced with 1 mM tris(2-carboxyethyl)
phosphine (bond breaker, 0.5 M solution, Thermo Fisher, Wal-
tham,MA) at room temperature for 30min. Cysteine alkylation
was performed using 2.2 l of 100 mM iodoacetamide for 30
min at room temperature while protected from light, and then
quenched with 10 mM dithiothreitol at room temperature for
15 min. The reduced and alkylated protein samples (	30 l)
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were digested overnight at 37 °C in 8 M urea with 1 g of endo-
proteinase Lys-C (2 l of a 0.5 g/l stock; Roche Applied
Science, Basel, Switzerland), then diluted 1:4 with 100mMTris,
pH 8.5, incubated with trypsin (Sigma) (	1:4 enzyme ratio) for
24 h at 37 °C, and acidified with aqueous 5% formic acid (3.3l)
(Fluka, St. Louis, MO; catalogue no. 56302). Peptides were
extracted with Nutip carbon tips (Glygen, Columbia, MD; cat-
alogue no. NT3CAR) that were preconditioned by repetitive
pipetting with 25l (three times) of the peptide elution solvent
(60% acetonitrile in 1% formic acid) followed by equilibration
with 10 washes (25 l) of extraction solvent (1% formic acid).
Samples were loaded with 50 pipetting cycles. The tips were
then washed four times with extraction solution. The peptides
were recovered by 20 pipetting cycles with 25 l of elution
solution and followed by four washes (20 l each) of elution
solution. The extraction and wash solutions were combined in
an autosampler vial (SunSri, Rockwood, TN) and dried in a
SpeedVac (Thermo Scientific Savant). AS2 autosampler vial
caps were from National Scientific (Rockwood, TN).
Nano-liquid Chromatography-Mass Spectrometry (LC-MS)—
A two-dimensional Plus LC (Eksigent, Dublin, CA) with a
Nanoflex module and an AS2 autosampler were coupled to a
TripleTOF 5600 Plusmass spectrometer (AB SCIEX). The two-
dimensional LC system was configured to load samples in tan-
dem. The CHiPLC columns (ChromXP C18 200 m  15 cm;
particle size 3 m, 120 Å) were equilibrated in 1% aqueous
formic acid (solvent A). Organic gradients were produced by
increasing the proportion of solvent B (1% formic acid in ace-
tonitrile): 0 min, 98% solvent A, 2% solvent B; 5 min, 98% A, 2%
B; 400 min, 65% A, 35% B; 450 min, 20% A, 80% B; ending at 60
min. Initial chromatographic conditions were restored in 5min
and maintained for 20 min. The samples were loaded in a vol-
ume of 10 l at a flow rate of 1.5 l/min followed by gradient
elution of peptides at a flow rate of 800 nl/min.
MS data acquisition was performed with a TripleTOF 5600
Plus (AB SCIEX) mass spectrometer interfaced to the nano-
chromatography with a Digital Picoview nanospray source
(New Objectives) via a 10-m Silica PicoTip emitter (New
Objectives) and operated with a resolution of30,000fwhm for
TOF-MS scans. Data were acquired with the ion spray voltage
at 2.9 kV, curtain gas at 10 p.s.i., nebulizer gas at 14 p.s.i., and the
interface heater temperature of 175 °C. For data-dependent
acquisition, survey scans were acquired in 250 ms; from these,
50 product ion scans were selected for MS2 acquisition with a
dwell time of 20ms. Four time bins were summed for each scan
at a frequency of 15.4 kHz (through monitoring of the 40 GHz
multichannel TDC detector with four-anode/channel detec-
tion). A rolling collision energy (CE) was applied to all precur-
sor ions for collision-induced dissociation using Equation 1,
CE slope m/z intercept (Eq. 1)
where the slope for all charge states above2 is 0.0625, and the
intercept is3,5, and6 for2,3, and4, respectively.
MS Data Processing and Protein Quantification—Data were
processed using the AB SCIEX MS Data Converter version 1.3
(AB SCIEX), converting the raw data files (*.wiff) tomgf files for
protein database searching. A copy of the Uniprot mouse ref-
erence database (downloaded Oct. 8, 2013, containing 43,296
entries) was used to perform a MASCOT (version 2.5.1) decoy
search allowing for up to fourmissed cleavages. The parent and
product mass search tolerances were set at 25 ppm and 0.1 Da,
respectively. Carbamidomethyl was set as a fixed modification
for cysteine residues, and methionine residue oxidation was
allowed as a variable modification. The protein database
searches were analyzed using Scaffold (version 4.4.8), and pro-
teins were identified using the Protein Prophet algorithm (65,
66) with protein and peptide thresholds at 1% and 0.1% false
discovery rate, respectively. Quantification of relative protein
abundancewas performed using spectral counting (67, 68) with
p values generated in Scaffold (version 4.0) using a Fisher’s
exact test (69). Proteins with at least five or greater spectral
counts were used to quantify changes in protein abundances.
Plasma vWF Quantitation—Plasma levels of vWF were
determined as described previously (70, 71).
Generation of Rat Anti-PSG23 Antibody—PSG23 consisting
of the N-terminal domain and the A-domain (PSG23N1A) fol-
lowed by the HRV 3C protease recognition sequence, Leu-Glu-
Val-Leu-Phe-Gln-Gly-Pro, a His6, and a FLAG tag was gener-
ated and purified as described previously (54). To generate the
anti-PSG23 antibody, rats were immunized with PSG23N1A
following in-column cleavage of the tags. Briefly, PSG23N1A
His FLAG purified with an anti-FLAG M2-agarose column
(Sigma) was equilibrated in protease (HRV 3C) reaction buffer
and applied to a HisTrap column (GEHealthcare). The column
was washed with 5 column volumes of reaction buffer followed
by the addition of 1 unit ofHRV3Cprotease (Pierce) per 100g
of PSG23N1A and incubated overnight. The cleaved protein
was eluted from the column, concentrated, buffer-exchanged
with PBS, and used as the immunogen.
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